[BioSnap] Penetrium Bio “Goes directly to phase 2 clinical trial in the U.S.”

(Seoul = Yonhap News) Reporter Park Sang-hyun = Penitrium Bioscience skipped phase 1 in the United States and conducted phase 2 in relation to the global clinical trial of its new drug candidate 'Penitrium'...